Company news: ALS
ALS released their third quarter update (for the quarter ending 31-Dec-15, FY end is 31-Mar). Unaudited net profit was within guidance, at $31m. Strong earnings growth was achieved from the company's Life Sciences (including both food / pharmaceutical and environmental testing), and Industrial divisions. However, difficult conditions were experienced in the Energy and Minerals divisions, given the difficult demand conditions. The company continues to right-size its energy operations, whilst looking to grow its Life Sciences division (including via acquisition).